Citi analyst Daniel Grosslight initiated coverage of Align Technology (ALGN) with a Buy rating and $240 price target The firm launched the animal health and dental sectors with a “cautiously optimistic” view. Citi favors the animal health group, saying the the “humanization” pet trend is real and should drive more spending. The firm’s top pick is Zoetis. It sees the weak macro backdrop pressuring the dental sector. Citi expects a trade-down to lower cost implants and orthodontics. Citi’s top dental pick is Henry Schein.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology added to ‘Tactical Outperform’ list at Evercore ISI
- Early notable gainers among liquid option names on March 19th
- Morning Movers: Canadian Solar sinks following fourth quarter results
- Elliott builds stake in Align, to seek ways to lift stock price, Bloomberg says
- Midday Fly By: Nvidia bullish on AI revenue, MasterCard to acquire BVNK